Gracell Biotechnologies Inc

GRCL:NASDAQ

RT Quote | NASDAQ | USD

Last | 4:00 PM EST

24.00

-0.60 (-2.44%)

Volume

601,697

52 week range

22.30 - 28.88

...

Loading . . .

KEY STATS

Open24.28
Day High24.88
Day Low23.74
Prev Close24.60
52 Week High28.88
52 Week High Date01/08/21
52 Week Low22.30
52 Week Low Date01/08/21
Market Cap314.64M
Shares Out13.11M
10 Day Average Volume-
Dividend-
Dividend Yield-
Beta
1 Year % Change-

RATIOS/PROFITABILITY

EPS (TTM)-0.44
P/E (TTM)-54.53
Fwd P/E (NTM)-
EBITDA (MRQ)-24.91M
ROE (MRQ)-
Revenue (MRQ)0.00M
Gross Margin (MRQ)-
Net Margin (MRQ)-
Debt To Equity (MRQ)24.60%

EVENTS

Earnings Date-
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest Gracell Biotechnologies Inc News

January 11, 2021

Gracell Biotechnologies CEO sees U.S.-China tension's impact minimized CNBC Video

Latest GRCL News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Market Movers

Profile

Gracell Biotechnologies Inc is a China-based clinical-stage biopharmaceutical company focused on discovering and developing cell therapies for the treatment of cancers. The Company is primarily focused on disrupting conventional approaches to chimeric antigen receptor (CAR) thymus (T) cell therapies by leveraging its technology platforms FasTCAR and TruUCAR. With FasTCAR, the Company is able to deliver younger, less exhausted T cells for autologous cell therapies with...

Address

Building 3

418 Guilin Road, Xuhui District

Shanghai, SHA

200030

China

http://www.gracellbio.com/